Descripción

Retatrutide 10mg — Triple Agonist for Metabolic Research

Retatrutide 10mg provides the same revolutionary triple GLP-1/GIP/glucagon receptor agonist mechanism as the 12mg vial at a 10mg dose. Clinical data shows dose-dependent weight loss with exceptional efficacy at all doses studied, making the 10mg formulation valuable for research protocols requiring precise lower dosing.

Principales ventajas

• Triple agonist: GLP-1R, GIPR, Glucagon R
• 10mg lyophilized powder per vial | Purity: ≥98%
• Almacenamiento: 2-8°C a corto plazo, -20°C a largo plazo
• Reconstituir con agua bacteriostática

Sólo para fines de investigación. No para consumo humano.